An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Aberrant telomerase reactivation in differentiated cells represents a major event in oncogenic transformation. Recurrent somatic mutations in the human telomerase reverse transcriptase (TERT) promoter region, predominantly localized to two nucleotide positions, are highly prevalent in many cancer types. Both mutations create novel consensus E26 transformation‐specific (ETS) motifs and are associated with increased TERT expression. Here, we perform an unbiased proteome‐wide survey of transcription factor binding at TERT promoter mutations in melanoma. We observe ELF1 binding at both mutations in vitro and we show that increased recruitment of GABP is enabled by the spatial architecture of native and novel ETS motifs in the TERT promoter region. We characterize the dynamics of competitive binding between ELF1 and GABP and provide evidence for ELF1 exclusion by transcriptionally active GABP. This study thus provides an important description of proteome‐wide, mutation‐specific binding at the recurrent, oncogenic TERT promoter mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799 · cited 3×
“Additionally, both mutations create novel E26 transformation-specific (ETS) transcription factor motifs within the TERT promoter region [7, 8].”
BackgroundKillela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368
Frequency of TERT promoter mutations in human cancers
Vinagre, J., Almeida, A., Pópulo, H., Batista, R., Lyra, J., Pinto, V., Coelho, R., Celestino, R., Prazeres, H., Lima, L., et al. (2013) · Nature Communications · doi:10.1038/ncomms3185 · Cited by 898
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Bell, R. J. A., Rube, H. T., Kreig, A., Mancini, A., Fouse, S. D., Nagarajan, R. P., Choi, S., Hong, C., He, D., Pekmezci, M., et al. (2015) · Science · doi:10.1126/science.aab0015 · Cited by 566 · cited 6×
“Indeed, recent work indicates that in the case of 250T, GABP still binds using ETS-195 and ETS-200 instead of upstream ETS motifs [15].”
BackgroundInfluentialGenome-wide analysis of noncoding regulatory mutations in cancer
Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. (2014) · Nature Genetics · doi:10.1038/ng.3101 · Cited by 484 · cited 1×
“Genome-wide analysis further confirmed TERT promoter mutations as the most consistently significant mutational hotspot across various cancer subtypes [11, 12].”
BackgroundQuantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions
Hubner, N. C., Bird, A. W., Cox, J., Splettstoesser, B., Bandilla, P., Poser, I., Hyman, A., & Mann, M. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911091 · Cited by 440 · cited 1×
“Plots were generated with Python essentially as described previously [28].”
MethodRegulation of Ets function by protein–protein interactions
Li, R., Pei, H., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204035 · Cited by 229 · cited 1×
“Although most ETS-transcription factors are reported to bind monomerically, cooperative, antagonistic, and combinatorial effects are common [33].”
BackgroundButter, F., Davison, L., Viturawong, T., Scheibe, M., Vermeulen, M., Todd, J. A., & Mann, M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002982 · Cited by 91
Self-citation
Cited by
The chromatin accessibility landscape of primary human cancers
Corces, M. R., Granja, J. M., Shams, S., Louie, B. H., Seoane, J. A., Zhou, W., Silva, T. C., Groeneveld, C., Wong, C. K., Cho, S. W., et al. (2018) · Science · doi:10.1126/science.aav1898 · Cited by 1,230
“Consistent with a previous report (50), differential motif analysis at the site of this TERT promoter mutation identified E74-like ETS transcription factor 1 (ELF1) or ELF2 as the TF that likely binds to the de novo ETS motif (fig.”
BackgroundTargeting transcription factors in cancer — from undruggable to reality
Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919
Targeting telomerase for cancer therapy
Guterres, A. N., & Villanueva, J. (2020) · Oncogene · doi:10.1038/s41388-020-01405-w · Cited by 256
High-throughput identification of human SNPs affecting regulatory element activity
(2019) · doi:10.1038/s41588-019-0455-2 · Cited by 205
Systematic identification of human SNPs affecting regulatory element activity
(2018) · doi:10.1101/460402 · Cited by 205
Metadata
- Authors
- Makowski, M. M., Willems, E., Fang, J., Choi, J., Zhang, T., Jansen, P. W. T. C., Brown, K. M., & Vermeulen, M.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2016-01-08
- Volume
- 16
- Issue
- 3
- Pages
- 417-426
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W2134567338
- Cited by
- 58
- References
- 9
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.